Mink Therapeutics Inc (INKT) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Mink Therapeutics Inc   (NASDAQ: INKT)

Mink Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information




INKT Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 75.25 % 64.9 % 48.39 %
Gross Margin (Q2 TTM) - 47.74 % 63.93 % 46.47 %
Gross Profit Margin 5 Yr. Avg. - 71.57 % 63.22 % 45.98 %
EBITDA Margin (Q2 MRQ) - 40.65 % 22.15 % 24 %
EBITDA Margin (Q2 TTM) - 26.41 % 20.55 % 19.1 %
EBITDA Margin 5 Yr. Avg. - 21.57 % 25.19 % 20.68 %
Operating Margin (Q2 MRQ) - 19.51 % 18.35 % 16.68 %
Operating Margin (Q2 TTM) - 5.06 % 16.4 % 15.73 %
Operating Margin 5 Yr. Avg. - 6.74 % 13.75 % 15.93 %
Pre-Tax Profit Margin (Q2 MRQ) - 27.79 % 14.32 % 13.69 %
Pre-Tax Profit Margin (Q2 TTM) - 14.17 % 12.45 % 12.56 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.39 % 10.33 % 11.45 %
Net Margin (Q2 MRQ) - 21.45 % 10.82 % 10.68 %
Net Margin (Q2 TTM) - 10.05 % 10.57 % 10.15 %
Net Margin 5 Yr. Avg. - 5.79 % 7.66 % 9.19 %